Medical Xpress - Cardiology
FEBRUARY 25, 2025
Researchers at the TechMed Center of the University of Twente and Radboud University Medical Center have removed blood clots with wireless magnetic robots. This innovation promises to transform treatment for life-threatening vascular conditions like thrombosis.
DAIC
APRIL 24, 2024
Blood clots are the third most common vascular disease. Almost one million patients suffer from peripheral blood clots that must be treated each year, and up to 33% of them suffer long-term complications, according to the Center for Disease Control.
Frontiers in Cardiovascular Medicine
JANUARY 30, 2025
However, innovation in MHV design faces several challenges: strict performance and biocompatibility requirements, limited understanding of the mechanisms underlying MHV thrombosis, and a lack of effective testing methodologies to assess how design variations impact both hemodynamic performance and thrombogenicity of MHVs.
DAIC
MARCH 24, 2025
The catheter is designed to elevate care for patients with venous thrombosis, a serious condition caused by a blood clot forming in the veins of the legs or abdomen that can have a life-threatening impact if left untreated. Food and Drug Administration (FDA) 510(k) clearance of the 82 cm version of its Symphony 16F catheter.
DAIC
MARCH 8, 2024
As an alternative therapeutic option, LVAD heart pumps have been implanted to help patients with end-stage heart failure sustain blood circulation in the body. However, there are shortcomings associated with LVAD implantation: complications include infection, blood clotting (thrombosis), stroke and bleeding.
DAIC
APRIL 4, 2024
Left Atrial Appendage Occlusion (LAAO) procedures are done to reduce the risk of stroke in patients with atrial fibrillation by sealing off the left atrial appendage, preventing the formation of blood clots. and globally." We're honored to introduce our cardiology module in collaboration with the ACC.
DAIC
JULY 24, 2024
Mohr-Durdez added, “To help enhance patient care in this field, Volta Medical aims to further integrate its AI solution with EP innovators to help increase compatibility and address the challenges clinicians face in analyzing cardiac electrical signals.” FDA 510(k) clearance and European CE Mark approval for its innovative products.
Expert insights. Personalized for you.
110 
Let's personalize your content